{"id":10409,"date":"2022-02-09T08:11:41","date_gmt":"2022-02-09T07:11:41","guid":{"rendered":"https:\/\/ggba.swiss\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/"},"modified":"2023-07-04T13:43:51","modified_gmt":"2023-07-04T11:43:51","slug":"adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/","title":{"rendered":"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d&rsquo;un nouveau partenariat"},"content":{"rendered":"\n<p>Bas\u00e9e \u00e0 Lausanne, <a href=\"https:\/\/www.adctherapeutics.com\/\" target=\"_blank\" rel=\"noopener\">ADC Therapeutics<\/a> est une soci\u00e9t\u00e9 de biotechnologie de stade commercial qui s&rsquo;attaque au cancer avec ses conjugu\u00e9s anticorps-m\u00e9dicaments (ADC) cibl\u00e9s de nouvelle g\u00e9n\u00e9ration. Le ZYNLONTA de la soci\u00e9t\u00e9 est un ADC ciblant le CD19.<\/p>\n<p>La Food and Drug Administration (FDA) am\u00e9ricaine a approuv\u00e9 ZYNLONTA pour le traitement de patients adultes atteints de lymphome \u00e0 grandes cellules B r\u00e9cidivant ou r\u00e9fractaire apr\u00e8s deux traitements syst\u00e9miques ou plus.<\/p>\n<p>ZYNLONTA est \u00e9galement en cours de d\u00e9veloppement en association avec d&rsquo;autres agents. En plus de l&rsquo;approbation de la FDA, une demande d&rsquo;autorisation de mise sur le march\u00e9 (Marketing Authorization Application, MAA) pour ZYNLONTA a \u00e9t\u00e9 valid\u00e9e par l&rsquo;Agence europ\u00e9enne des m\u00e9dicaments (EMA) et est en cours d&rsquo;examen par le Comit\u00e9 des m\u00e9dicaments \u00e0 usage humain (CHMP) de l&rsquo;EMA.<\/p>\n<h4>Mettre ZYNLONTA \u00e0 la port\u00e9e des patients du monde entier<\/h4>\n<p>La soci\u00e9t\u00e9 pharmaceutique japonaise <a href=\"https:\/\/www.mt-pharma.co.jp\/e\/\" target=\"_blank\" rel=\"noopener\">Mitsubishi Tanabe Pharma Corporation<\/a> (MTPC) a re\u00e7u les droits exclusifs pour d\u00e9velopper et commercialiser ZYNLONTA pour toutes ses applications h\u00e9matologiques et pour les tumeurs solides au Japon. Selon les termes de l&rsquo;accord, ADC Therapeutics recevra un paiement initial de USD 30 millions et jusqu&rsquo;\u00e0 USD 205 millions suppl\u00e9mentaires en paiements \u00e9chelonn\u00e9s si certains objectifs de d\u00e9veloppement et de commercialisation sont atteints.<\/p>\n<p>En outre, la soci\u00e9t\u00e9 vaudoise recevra des redevances dont le pourcentage variera entre un maximum et un minimum de 20 %, en fonction des ventes nettes du produit au Japon. MTPC m\u00e8nera des \u00e9tudes cliniques sur ZYNLONTA au Japon et aura le droit de participer \u00e0 toute \u00e9tude clinique mondiale du produit en prenant en charge une partie des co\u00fbts de l&rsquo;\u00e9tude.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le nouveau partenariat d&rsquo;ADC Therapeutics portera sur le d\u00e9veloppement et la commercialisation de ZYNLONTA au Japon, pour lequel la soci\u00e9t\u00e9 vaudoise recevra un paiement initial de USD 30 millions.<\/p>\n","protected":false},"author":3,"featured_media":10410,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1022,1065,1069],"class_list":["post-10409","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr","tag-oncology-fr","tag-pharma-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d&#039;un nouveau partenariat - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d&#039;un nouveau partenariat - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Le nouveau partenariat d&#039;ADC Therapeutics portera sur le d\u00e9veloppement et la commercialisation de ZYNLONTA au Japon, pour lequel la soci\u00e9t\u00e9 vaudoise recevra un paiement initial de USD 30 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-09T07:11:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d&rsquo;un nouveau partenariat\",\"datePublished\":\"2022-02-09T07:11:41+00:00\",\"dateModified\":\"2023-07-04T11:43:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/\"},\"wordCount\":306,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg\",\"keywords\":[\"Biotech\",\"Oncology\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/\",\"name\":\"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d'un nouveau partenariat - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg\",\"datePublished\":\"2022-02-09T07:11:41+00:00\",\"dateModified\":\"2023-07-04T11:43:51+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d&rsquo;un nouveau partenariat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d'un nouveau partenariat - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/","og_locale":"fr_FR","og_type":"article","og_title":"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d'un nouveau partenariat - Greater Geneva Bern area","og_description":"Le nouveau partenariat d'ADC Therapeutics portera sur le d\u00e9veloppement et la commercialisation de ZYNLONTA au Japon, pour lequel la soci\u00e9t\u00e9 vaudoise recevra un paiement initial de USD 30 millions.","og_url":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2022-02-09T07:11:41+00:00","article_modified_time":"2023-07-04T11:43:51+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d&rsquo;un nouveau partenariat","datePublished":"2022-02-09T07:11:41+00:00","dateModified":"2023-07-04T11:43:51+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/"},"wordCount":306,"image":{"@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg","keywords":["Biotech","Oncology","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/","url":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/","name":"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d'un nouveau partenariat - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg","datePublished":"2022-02-09T07:11:41+00:00","dateModified":"2023-07-04T11:43:51+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/ADC-Therapeutics-630x380-1-2.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/adc-therapeutics-decroche-usd-30-millions-dans-le-cadre-dun-nouveau-partenariat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"ADC Therapeutics d\u00e9croche USD 30 millions dans le cadre d&rsquo;un nouveau partenariat"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=10409"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10409\/revisions"}],"predecessor-version":[{"id":18086,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/10409\/revisions\/18086"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/10410"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=10409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=10409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=10409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}